✦ LIBER ✦

Model for end-stage liver disease (MELD) exception guidelines

✍ Scribed by Russell Wiesner; John R. Lake; Richard B. Freeman; Robert G. Gish

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 64 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20961

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula

✍ Richard B. Freeman Jr.; Robert G. Gish; Ann Harper; Gary L. Davis; John Vierling 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Determining need for liver transplantation (LT) can be effectively estimated when the actual liver disease is highly likely to cause death in the near future. However, for many conditions, the liver disease itself does not carry a high risk of short-term mortality, and other factors contribute to de

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for polycystic liver disease

✍ Luis Arrazola; Dilip Moonka; Robert G. Gish; Gregory T. Everson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients wh

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for ascites

✍ Scott W. Biggins; Steven Colquhoun; Robert G. Gish; Bruce A. Runyon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for bacterial cholangitis

✍ Gregory J. Gores; Robert G. Gish; Roshan Shrestha; Russell H. Wiesner 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for cystic fibrosis

✍ Simon Horslen; Stuart Sweet; Robert G. Gish; Ross Shepherd 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

Cystic fibrosis (CF) is a multisystem disease caused by mutations in a single gene (cystic fibrosis transmembrane conductance regulator) and is the most frequent potentially fatal inherited condition in whites, occurring in 1 in 2,000 births. Progressive pulmonary disease is the major contributor to

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) exception for hepatic encephalopathy

✍ John Ham; Robert G. Gish; Kevin Mullen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views